Sort   by:  
 Page size 
Extracellular vesicles (EV) in body fluids are extensively studied as potential biomarkers for numerous diseases. Major impediments of EV-based biomarker discovery include the manual labor, and the specificity and reproducibility of EV sample preparation. To tackle this, we present an automated liqu...
ORGANISM(S): Homo sapiens (Human) 
2023-05-10 | PXD032394 | Pride
As tissue engineering and high-throughput disease modeling develop further, necessitating large quantities of viable cells, automation will be essential. Robotic liquid handling systems are increasingly employed for generating large quantities of induced pluripotent stem cell (iPSC)-derived cells, w...
ORGANISM(S): Homo sapiens (Human) 
2026-09-28 | PXD070184 | Pride
This Series is composed of the following Samples: GSM375647: Taichung 65_shoot_replicate 1 GSM375648: Taichung 65_shoot_replicate 2 GSM375649: Taichung 65_shoot_replicate 3 GSM375765: gid1-3_ shoot_replicate 1 GSM375766: gid1-3_ shoot_replicate 2 GSM375767: gid1-3_ shoot_replicate 3 GSM375769: gid2-...
ORGANISM(S): Oryza sativa 
To better understand the molecular mechanisms underpinning physiological variation in human populations, metabolic phenotyping approaches are increasingly being applied to studies involving hundreds and thousands of biofluid samples. Hyphenated ultra-performance liquid chromatography-mass spectromet...
2022-03-01 | MTBLS719 | MetaboLights
Toxicometabolomics, essentially applying metabolomics to toxicology of endogenous compounds such as drugs of abuse or new psychoactive substances (NPS), can be investigated by using different in vitro models and dedicated metabolomics techniques to enhance the number of relevant findings. The presen...
2023-10-10 | MTBLS1481 | MetaboLights

Fecal microbiota transplantation (FMT) represents a potential strategy to overcome resistance to immune checkpoint inhibitors in patients with refractory melanoma; however, the role of FMT in first-line treatment settings has not been evaluated. We conducted a multicenter phase I trial combining ...

2025-02-27 | MTBLS711 | MetaboLights
Sort   by:  
 Page size